Global Dolutegravir Market Size, Share, and COVID-19 Impact Analysis, By Type (10mg Tablets and 50mg Tablets), By Application (Prevent HIV Infection Following Potential Exposure, Treatment of HIV Infection, and Pediatric Use), By End-user (Hospitals, Clinics, Home care, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Feb 2026
REPORT ID SI17794
PAGES 265
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type
      2. Market Attractiveness Analysis By Application
      3. Market Attractiveness Analysis By End-user
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Affordable generics and large-scale procurement in LMICs
    3. Restraints
      1.  Drug resistance, side effects, and competition from newer antivirals
    4. Opportunities
      1.  Pediatric formulations, two-drug regimens, and expanded access in emerging markets
    5. Challenges

5.5.1.     Healthcare infrastructure gaps, diagnostic limitations, and regulatory barriers

  1. Global Dolutegravir Market Analysis and Projection, By Type
    1. Segment Overview
    2. 10mg Tablets
    3. 50mg Tablets
  2. Global Dolutegravir Market Analysis and Projection, By Application
    1. Segment Overview
    2. Prevent HIV Infection Following Potential Exposure
    3. Treatment of HIV Infection
    4. Pediatric Use
  3. Global Dolutegravir Market Analysis and Projection, By End-user
    1. Segment Overview
    2. Hospitals
    3. Clinics
    4. Home care
    5. Others
  4. Global Dolutegravir Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  5. Global Dolutegravir Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Dolutegravir Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  6. Company Profiles
    1. Aurobindo Pharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   ViiV Healthcare 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Mylan N.V. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Adcock Ingram Limited 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Sun Pharmaceutical Industries 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Aurobindo Pharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Cipla Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Laurus Labs
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Emcure Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Hetero Labs Limited 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Desano Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Zydus Lifesciences Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Dolutegravir Market, By Type, 2024-2035(USD Billion)
  2. Global 10mg Tablets, Dolutegravir Market, By Region, 2024-2035(USD Billion)
  3. Global 50mg Tablets, Dolutegravir Market, By Region, 2024-2035(USD Billion)
  4. Global Dolutegravir Market, By Application, 2024-2035(USD Billion)
  5. Global Prevent HIV Infection Following Potential Exposure, Dolutegravir Market, By Region, 2024-2035(USD Billion)
  6. Global Treatment of HIV Infection, Dolutegravir Market, By Region, 2024-2035(USD Billion)
  7. Global Pediatric Use, Dolutegravir Market, By Region, 2024-2035(USD Billion)
  8. Global Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  9. Global Hospitals, Dolutegravir Market, By Region, 2024-2035(USD Billion)
  10. Global Clinics, Dolutegravir Market, By Region, 2024-2035(USD Billion)
  11. Global Home care, Dolutegravir Market, By Region, 2024-2035(USD Billion)
  12. Global Others, Dolutegravir Market, By Region, 2024-2035(USD Billion)
  13. North America Dolutegravir Market, By Type, 2024-2035(USD Billion)
  14. North America Dolutegravir Market, By Application, 2024-2035(USD Billion)
  15. North America Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  16. U.S.  Dolutegravir Market, By Type, 2024-2035(USD Billion)
  17. U.S.  Dolutegravir Market, By Application, 2024-2035(USD Billion)
  18. U.S.  Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  19. Canada Dolutegravir Market, By Type, 2024-2035(USD Billion)
  20. Canada Dolutegravir Market, By Application, 2024-2035(USD Billion)
  21. Canada Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  22. Mexico Dolutegravir Market, By Type, 2024-2035(USD Billion)
  23. Mexico Dolutegravir Market, By Application, 2024-2035(USD Billion)
  24. Mexico Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  25. Europe Dolutegravir Market, By Type, 2024-2035(USD Billion)
  26. Europe Dolutegravir Market, By Application, 2024-2035(USD Billion)
  27. Europe Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  28. Germany Dolutegravir Market, By Type, 2024-2035(USD Billion)
  29. Germany Dolutegravir Market, By Application, 2024-2035(USD Billion)
  30. Germany Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  31. France Dolutegravir Market, By Type, 2024-2035(USD Billion)
  32. France Dolutegravir Market, By Application, 2024-2035(USD Billion)
  33. France Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  34. U.K.  Dolutegravir Market, By Type, 2024-2035(USD Billion)
  35. U.K.  Dolutegravir Market, By Application, 2024-2035(USD Billion)
  36. U.K.  Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  37. Italy Dolutegravir Market, By Type, 2024-2035(USD Billion)
  38. Italy Dolutegravir Market, By Application, 2024-2035(USD Billion)
  39. Italy Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  40. Spain Dolutegravir Market, By Type, 2024-2035(USD Billion)
  41. Spain Dolutegravir Market, By Application, 2024-2035(USD Billion)
  42. Spain Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  43. Asia Pacific Dolutegravir Market, By Type, 2024-2035(USD Billion)
  44. Asia Pacific Dolutegravir Market, By Application, 2024-2035(USD Billion)
  45. Asia Pacific Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  46. Japan Dolutegravir Market, By Type, 2024-2035(USD Billion)
  47. Japan Dolutegravir Market, By Application, 2024-2035(USD Billion)
  48. Japan Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  49. China Dolutegravir Market, By Type, 2024-2035(USD Billion)
  50. China Dolutegravir Market, By Application, 2024-2035(USD Billion)
  51. China Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  52. India Dolutegravir Market, By Type, 2024-2035(USD Billion)
  53. India Dolutegravir Market, By Application, 2024-2035(USD Billion)
  54. India Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  55. South America Dolutegravir Market, By Type, 2024-2035(USD Billion)
  56. South America Dolutegravir Market, By Application, 2024-2035(USD Billion)
  57. South America Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  58. Brazil Dolutegravir Market, By Type, 2024-2035(USD Billion)
  59. Brazil Dolutegravir Market, By Application, 2024-2035(USD Billion)
  60. Brazil Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  61. The Middle East and Africa Dolutegravir Market, By Type, 2024-2035(USD   Billion)
  62. The Middle East and Africa Dolutegravir Market, By Application, 2024-2035(USD   Billion)
  63. The Middle East and Africa Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  64. UAE Dolutegravir Market, By Type, 2024-2035(USD Billion)
  65. UAE Dolutegravir Market, By Application, 2024-2035(USD Billion)
  66. UAE Dolutegravir Market, By End-user, 2024-2035(USD Billion)
  67. South Africa Dolutegravir Market, By Type, 2024-2035(USD Billion)
  68. South Africa Dolutegravir Market, By Application, 2024-2035(USD Billion)
  69. South Africa Dolutegravir Market, By End-user, 2024-2035(USD Billion)

List of Figures 

  1. Global Dolutegravir Market Segmentation
  2. Dolutegravir Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Dolutegravir Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Dolutegravir Market
  20. Dolutegravir Market Segmentation, By Type
  21. Dolutegravir Market For 10mg Tablets, By Region, 2024-2035 ($ Billion)
  22.  Dolutegravir Market For 50mg Tablets, By Region, 2024-2035 ($ Billion)
  23.  Dolutegravir Market Segmentation, By Application
  24.  Dolutegravir Market For Prevent HIV Infection Following Potential Exposure, By Region, 2024-2035 ($ Billion)
  25.  Dolutegravir Market For Treatment of HIV Infection, By Region, 2024-2035 ($ Billion)
  26. Dolutegravir Market For Pediatric Use, By Region, 2024-2035 ($ Billion)

 

  1. Dolutegravir Market Segmentation, By End-user
  2. Dolutegravir Market For Hospitals, By Region, 2024-2035 ($ Billion)
  3. Dolutegravir Market For Clinics, By Region, 2024-2035 ($ Billion)
  4. Dolutegravir Market For Home care, By Region, 2024-2035 ($ Billion)
  5. Dolutegravir Market For Others, By Region, 2024-2035 ($ Billion)

 

  1. Aurobindo Pharma: Net Sales, 2024-2035 ($ Billion)
  2. Aurobindo Pharma: Revenue Share, By Segment, 2024 (%)
  3. Aurobindo Pharma: Revenue Share, By Region, 2024 (%)
  4. ViiV Healthcare: Net Sales, 2024-2035 ($ Billion)
  5. ViiV Healthcare: Revenue Share, By Segment, 2024 (%)
  6. ViiV Healthcare: Revenue Share, By Region, 2024 (%)
  7. Mylan N.V.: Net Sales, 2024-2035 ($ Billion)
  8. Mylan N.V.: Revenue Share, By Segment, 2024 (%)
  9. Mylan N.V.: Revenue Share, By Region, 2024 (%)
  10. Adcock Ingram Limited: Net Sales, 2024-2035 ($ Billion)
  11. Adcock Ingram Limited: Revenue Share, By Segment, 2024 (%)
  12. Adcock Ingram Limited: Revenue Share, By Region, 2024 (%)
  13. Sun Pharmaceutical Industries: Net Sales, 2024-2035 ($ Billion)
  14. Sun Pharmaceutical Industries: Revenue Share, By Segment, 2024 (%)
  15. Sun Pharmaceutical Industries: Revenue Share, By Region, 2024 (%)
  16. Sun Pharmaceutical Industries: Net Sales, 2024-2035 ($ Billion)
  17. Sun Pharmaceutical Industries: Revenue Share, By Segment, 2024 (%)
  18. Sun Pharmaceutical Industries: Revenue Share, By Region, 2024 (%)
  19. Cipla Ltd.: Net Sales, 2024-2035 ($ Billion)
  20. Cipla Ltd.: Revenue Share, By Segment, 2024 (%)
  21. Cipla Ltd.: Revenue Share, By Region, 2024 (%)
  22. Laurus Labs: Net Sales, 2024-2035 ($ Billion)
  23. Laurus Labs: Revenue Share, By Segment, 2024 (%)
  24. Laurus Labs: Revenue Share, By Region, 2024 (%)
  25. Emcure Pharmaceuticals.: Net Sales, 2024-2035 ($ Billion)
  26. Emcure Pharmaceuticals.: Revenue Share, By Segment, 2024 (%)
  27. Emcure Pharmaceuticals.: Revenue Share, By Region, 2024 (%)
  28. Hetero Labs Limited: Net Sales, 2024-2035 ($ Billion)
  29. Hetero Labs Limited: Revenue Share, By Segment, 2024 (%)
  30. Hetero Labs Limited: Revenue Share, By Region, 2024 (%)
  31. Desano Inc.: Net Sales, 2024-2035 ($ Billion)
  32. Desano Inc.: Revenue Share, By Segment, 2024 (%)
  33. Desano Inc.: Revenue Share, By Region, 2024 (%)
  34. Zydus Lifesciences Limited: Net Sales, 2024-2035 ($ Billion)
  35. Zydus Lifesciences Limited: Revenue Share, By Segment, 2024 (%)
  36. Zydus Lifesciences Limited: Revenue Share, By Region, 2024 (%)
  37. Others: Net Sales, 2024-2035 ($ Billion)
  38. Others: Revenue Share, By Segment, 2024 (%)
  39. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:131
Pages:265
Countries covered:16
Companies covered::18
Forecast CAGR:5.1%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies